Theodore Logan, MD
Disclosures: Other (please describe below)-Local PI-Prometheus|Other (please describe below)-Local PI-Abbott|Other (please describe below)-Local PI-Abraxis|Other (please describe below)-Local PI-Accceleron|Other (please describe below)-Local PI-Amgen|Other (please describe below)-Local PI-Agros|Other (please describe below)-Local PI-AstraZeneca|Other (please describe below)-Local PI-Aveo|Other (please describe below)-Local PI-Bristol-Myers Squibb|Other (please describe below)-Local PI-Eisai, Inc.|Research Grant-Eli Lilly and Company|Other (please describe below)-Local PI-Glaxo Smith Kline|Other (please describe below)-Local PI-Roche|Other (please describe below)-Local PI-Immatics|Other (please describe below)-Local PI-Macrogenics|Other (please describe below)-Local PI-Merck and Company, Inc.|Other (please describe below)-Local PI-Novartis AG|Research Grant-Peloton|Other (please describe below)-Local PI-Pfizer, Inc.|Other (please describe below)-Local PI-Synta|Other (please describe below)-Local PI-Threshold|Other (please describe below)-Local PI-Tracon|Other (please describe below)-Local PI-Millenium|Other (please describe below)-Local PI-Cerulean|Other (please describe below)-Local PI-EMD Serono|Other (please describe below)-Local PI-Dynavax|Other (please describe below)-Local PI-Iovance|Other (please describe below)-Local PI-Eli Lilly and Company|Other (please describe below)-Local PI-Medimmune|Other (please describe below)-Local PI-Peloton
No Bio Available.